IP Verse

Method For Inactivation/Removal Of Coagulation Factors By Precipitation - EP2670429B1

PatentPatent Analysis

EP2670429

OCTAPHARMA
Application Number
EP12702825A
Filing Date
Feb 3, 2012
Status
Revoked
Jul 23, 2021
Grant Date
Apr 4, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3626737B1
EP2707387B1
EP2640413B1

Bibliography

The patent EP2670429B1 was granted to Octapharma on Apr 4, 2018 following the initial filing on Feb 3, 2012 under the application number EP12702825A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJan 4, 2019ADMISSIBLE
BIOTESTDec 21, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents